SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640455-19-000025
Filing Date
2019-04-23
Accepted
2019-04-23 08:21:40
Documents
5
Period of Report
2019-04-23
Effectiveness Date
2019-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A jnce04232019def14a.htm DEF 14A 483372
2 jounce2019proxycard01.jpg GRAPHIC 511654
3 jounce2019proxycard02.jpg GRAPHIC 429349
4 jouncelogo1.gif GRAPHIC 66963
5 rmsignature.jpg GRAPHIC 2641
  Complete submission text file 0001640455-19-000025.txt   1875718
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37998 | Film No.: 19760689
SIC: 2836 Biological Products, (No Diagnostic Substances)